» Articles » PMID: 28946652

Changes in Cognition and Decision Making Capacity Following Brain Tumour Resection: Illustrated with Two Cases

Overview
Journal Brain Sci
Publisher MDPI
Date 2017 Sep 27
PMID 28946652
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Changes in cognition, behaviour and emotion frequently occur in patients with primary and secondary brain tumours. This impacts the ability to make considered decisions, especially following surgical resection, which is often overlooked in the management of patients. Moreover, the impact of cognitive deficits on decision making ability affects activities of daily living and functional independence. The assessment process to ascertain decision making capacity remains a matter of debate. One avenue for evaluating a patient's ability to make informed decisions in the context of brain tumour resection is neuropsychological assessment. This involves the assessment of a wide range of cognitive abilities on standard measurement tools, providing a robust approach to ascertaining capacity. Evidence has shown that a comprehensive and tailored neuropsychological assessment has greater sensitivity than brief cognitive screening tools to detect subtle and/or specific cognitive deficits in brain tumours. It is the precise nature and severity of any cognitive deficits that determines any implications for decision making capacity. This paper focuses on cognitive deficits and decision making capacity following surgical resection of both benign and malignant, and primary and secondary brain tumours in adult patients, and the implications for patients' ability to consent to future medical treatment and make decisions related to everyday activities.

Citing Articles

Integration of 3D-printed cerebral cortical tissue into an ex vivo lesioned brain slice.

Jin Y, Mikhailova E, Lei M, Cowley S, Sun T, Yang X Nat Commun. 2023; 14(1):5986.

PMID: 37794031 PMC: 10551017. DOI: 10.1038/s41467-023-41356-w.


Acceptability and feasibility of cognitive assessments with adults with primary brain cancer and brain metastasis: A systematic review.

Carlson M, Fradgley E, Yates D, Morris S, Tait J, Paul C Neurooncol Pract. 2023; 10(3):219-237.

PMID: 37188159 PMC: 10180383. DOI: 10.1093/nop/npac097.


Augmented reality visualization of hyperspectral imaging classifications for image-guided brain tumor phantom resection.

Huang J, Halicek M, Shahedi M, Fei B Proc SPIE Int Soc Opt Eng. 2020; 11315.

PMID: 32606488 PMC: 7325483. DOI: 10.1117/12.2549041.


The Extracellular Matrix and Biocompatible Materials in Glioblastoma Treatment.

Belousov A, Titov S, Shved N, Garbuz M, Malykin G, Gulaia V Front Bioeng Biotechnol. 2019; 7:341.

PMID: 31803736 PMC: 6877546. DOI: 10.3389/fbioe.2019.00341.

References
1.
Schmand B, Gouwenberg B, Smit J, Jonker C . Assessment of mental competency in community-dwelling elderly. Alzheimer Dis Assoc Disord. 1999; 13(2):80-7. DOI: 10.1097/00002093-199904000-00004. View

2.
Dimitrov M, Granetz J, Peterson M, Hollnagel C, Alexander G, Grafman J . Associative learning impairments in patients with frontal lobe damage. Brain Cogn. 1999; 41(2):213-30. DOI: 10.1006/brcg.1999.1121. View

3.
Mezey M, Teresi J, Ramsey G, Mitty E, Bobrowitz T . Decision-making capacity to execute a health care proxy: development and testing of guidelines. J Am Geriatr Soc. 2000; 48(2):179-87. DOI: 10.1111/j.1532-5415.2000.tb03909.x. View

4.
Bechara A, Damasio H, Damasio A . Emotion, decision making and the orbitofrontal cortex. Cereb Cortex. 2000; 10(3):295-307. DOI: 10.1093/cercor/10.3.295. View

5.
Tucha O, Smely C, Preier M, Lange K . Cognitive deficits before treatment among patients with brain tumors. Neurosurgery. 2000; 47(2):324-33; discussion 333-4. DOI: 10.1097/00006123-200008000-00011. View